Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by wesdevrieson Dec 09, 2013 5:50pm
225 Views
Post# 21987617

RE:RE:RE:Sept. Presentation Posted:

RE:RE:RE:Sept. Presentation Posted:Well, alcohol "transcends" the brain barrier no problem; and so I better sit down and have a drink if  we are "old" news! But...I don't think so...hmmm...I think I'm going to have that drink! Sometimes...just sometimes, the more I drink...the more I may think...about the mystery of what lukemea might be? Actually I know somebody  who'll know what it means....our resident literary giant hillbillyjedd or jekyl or mp4 boy or whatever his name is...he'll know! But he's mad I think at me...I'm shore he's not tellen'! So what do I have left...I've got a half bottle of Merlot left, a bottle of Chardonnay, a bodle of Baileys, a butle of wum, tha mainder of Valliuminun scriptins, an a box of chocletz. Yu haf no idr how fablus I feel rite now. Snedd this to all who need inner piss. An telum u luvum like I do.

my words...not yours! LOL

wdv
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities